EDA Medical Devices Technology Inc.

EDA500 Epidural space locator, can help physicians perform operations safely and easily, avoiding uncontrollable risk factors in traditional operations.
Two-Photon Optical fiber Fluorescence Probe, can be obtained can identify abnormal cells or tumors in real time, and can obtain data continuity of the same in vivo experiment.
Laser irradiation device and Optical Fiber Needle (ILIB), to establish preventive medicine that promotes health and stays away from chronic hypoxia and sub-health,
EDA500 Epidural space locator, can help physicians perform operations safely and easily, avoiding uncontrollable risk factors in traditional operations.
Two-Photon Optical fiber Fluorescence Probe, can be obtained can identify abnormal cells or tumors in real time, and can obtain data continuity of the same in vivo experiment.
Laser irradiation device and Optical Fiber Needle (ILIB), to establish preventive medicine that promotes health and stays away from chronic hypoxia and sub-health.

eHo Smart Tech Co. Ltd.

HJ EECP device is All-in-One. It collects the patient ECG signal, conducts instant R-wave detection, and uses the R-wave trigger to control the inflation and deflation of the air bag. Inflation is a three-level sequential pressurization from the patient calves, thighs to buttocks and upper arms, so that the blood of the upper and lower limbs can be driven back to the upper body during diastole and returned to the heart through the veins, thus promoting the function of the heart, brain and other organs. blood circulation to improve blood supply to ischemic tissues.
Hyperbaric oxygen chamber (HBOT MEDICAL), equipped with emergency pressure relief valve, screens and call, air conditioning, touch screen real-time display of O2, CO2, temperature, humidity and pressure, etc., suitable for Alzheimer's disease, Parkinson's disease, diabetes, hypertension, wound repair, osteoporosis, etc.:
1. 1.5ATA (M50); 1 person; Atmospheric pressure: 1.1～1.5ATA (10-50kPa)
2. 2ATA (M200); 1 person; Atmospheric pressure: 1.1～2.0ATA (10-100kPa)

Eir Innotech Inc.

Flores Smart Inhaler - The Next Generation of Asthma Care AIoT Asthma is a growing chronic disease in most developed countries, with an average prevalence rate of around 10%. However, medication compliance is commonly noted as a major barrier to effective asthma control. With the advent of IoT technology, the Flores Smart Inhaler is an add-on device that can be attached to major asthma medications. By integrating with a mobile application via BLE communication, the personalized assistant manages and reminds patients about proper medicine use. Unlike typical prior applications, the patented flow detection technology not only captures drug usage activity but also details the quality attributes of each inhalation, such as duration, peak flow, volume capacity, and flow pattern. The Flores Smart Inhaler is an effective solution to mitigate the compliance barrier of asthma medication. Beyond this breakthrough, the data associated with this novel sensor platform further enables a more personalized and smarter asthma care ecosystem.

En Chu Kong Hospital

planning

EPED Inc.

EPROB
Robotic Arm and Stereotactic System for Brain Surgery

RETINA
Stereotactic Surgery Navigation System

RETINA Elite
Positioning System for rTMS

Pvix Oral
Augmented Reality Oral Health Training System

Pvix VR
Virtual Reality Medical and Healthcare Professional Training System

EpiSante Biomedical Co., Ltd.

EpiSante Biomed focuses on DNA methylation testing services. Our R&D team has over 20 years of experience in methylation research and has established core technologies, including a whole-genome methylation analysis platform, AI big data analysis, a liver cancer gene methylation database, liquid biopsy sample preprocessing, quantitative/qualitative methylation analysis, and the development of testing reagents/kits. Our products and services include methylation reagent kits, such as cell-free DNA extraction, bisulfite conversion, and cancer gene qMSP kits. We offer methylation testing services covering three major areas: functional medicine, preventive medicine, and precision medicine. Functional medicine testing includes immunity assessment testing, whole-body DNA methylation testing, tumor suppressor gene methylation testing, and exosome functional analysis. In preventive medicine, we offer MPM early liver cancer screening, LiverMeth liver cancer gene methylation testing, and CancerMeth pan-cancer methylation testing. In precision medicine, we provide LiverRP postoperative prognosis, LiverAM ablation monitoring, and companion diagnostics for immunotherapy/cell therapy. EpiSante Biomed focuses on the clinical applications of precision medicine at various stages, including early cancer diagnosis, disease prognosis, treatment evaluation, and recurrence monitoring. Our goal is to help the general public, sub-healthy individuals, and cancer patients detect issues early and take appropriate personalized medical actions, thereby improving quality of life.

EUCARE Co., Ltd.

NA

EUCRASIA

EUCRASIA contributes to the development of various communities and individuals in the healthcare and co-medical fields, by designing and embodying the harmony of the components of health in modern society through the latest ICT and theories. In January 2021, we were established as a new strategic subsidiary of the BOW Holdings Group to play a central role in the healthcare business. We will contribute to society through the use of data as an innovative player leading technological innovation in the healthcare and co-medical fields at home and abroad.

EVER FORTUNE.AI CO., LTD.

EverFortune.AI provides 3 categories of product:
Medical AI suites, Cloud Medical Platforms and Medical Big Data.
We believe our Holistic Healthcare AI Solutions Bring Better Medical Outcomes.
1. EFAI Solutions and Products
2. EFAI FDA Clearance Systems
3. EFAI RT Suite CT HCAP-Segmentation System

Ever Supreme Bio Technology Co., LTD

UMSC01 is the first drug in Taiwan to receive approval for a New Drug Application from the U.S. FDA and the go-ahead from the Taiwan FDA for clinical trials. This breakthrough treatment for multiple sclerosis is now undergoing Phase I and IIa clinical trials in Taiwan. Starting in September 2023, we have initiated SIV for patient enrollment. This year, we showcased UMSC01 at the BIO International Convention and the Japan Bioindustry Association Expo, drawing attention from numerous global companies. Get to know Ever Supreme and our pioneering efforts in medical innovation.